Depeptidized inhibitors of hepatitis C virus NS3 protease

Details Depeptidized inhibitors of hepatitis C virus NS3 protease Depeptidized inhibitors of hepatitis C virus NS3 protease

2007-08-07

2007-08-07

Kifle, Bruck (Department: 1624)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Heterocyclic carbon compounds containing a hetero ring...

C514S226500, C514S309000, C514S312000, C540S456000, C540S460000, C546S141000, C546S153000

Reexamination Certificate

active

10993394

ABSTRACT:
The present invention discloses novel depeptidized compounds which have HCV protease inhibitory activity as well as pharmaceutical compositions comprising such compounds and methods of using them to treat disorders associated with the HCV protease.

REFERENCES:
patent: 5712145 (1998-01-01), Houghton
patent: 6608027 (2003-08-01), Tsantrizos
patent: 0 381 216 (1995-12-01), None
patent: WO 89/04669 (1989-06-01), None
patent: WO 98/14181 (1998-04-01), None
patent: WO 98/17679 (1998-04-01), None
patent: WO 98/22496 (1998-05-01), None
patent: WO 99/07734 (1999-02-01), None
patent: WO 00/09543 (2000-02-01), None
patent: WO 00/09558 (2000-02-01), None
patent: WO OO/09543 (2000-02-01), None
patent: WO 00/59929 (2000-10-01), None
patent: WO 01/74768 (2001-10-01), None
patent: WO 01/77113 (2001-10-01), None
patent: WO 01/81325 (2001-11-01), None
patent: WO 02/08198 (2002-01-01), None
patent: WO 02/08244 (2002-01-01), None
patent: WO 02/08251 (2002-01-01), None
patent: WO 02/08256 (2002-01-01), None
patent: WO 02/48172 (2002-06-01), None
International Search report for PCT/US2004/039131 dated Nov. 19, 2004 for IN06122US01—5 Pages.
Berenguer, Marina, et al., “Hepatitis B and C Viruses: Molecular Identification and Targeted Antiviral Therapies,” Proceedings of the Association of American Physicians, 110(2):98-112 (1998).
Dimasi, Nazzareno, et al., “Characterization of Engineered Hepatitis C Virus NS3 Protease Inhibitors Affinity Selected from Human Pancreatic Secretory Trypsin Inhibitor and Minibody Repertoires,” Journal of Virology 71(10):7461-7469 (1997).
Elzouki, Abdul-Nasser, et al., “Serine protease inhibitors in patients with chronic viral hepatitis,” Journal of Hepatology 27:42-48 (1997).
Failla, Cristina Maria, et al., “Redesigning the substrate specificity of the hepatitis C virus NS3 protease,” Folding & Design 1(1):35-42 (1996).
Han, Wei, et al., “Alpha-Ketoamides, Alpha-Ketoesters and Alpha-Diketones as HCV NS3 Protease Inhibitors,” Bioorganic & Medicinal Chemistry Letters 10:711-713 (2000).
Hoofnagle, Jay H., et al., “The Treatment of Chronic Viral Hepatitis,” Drug Therapy 336(5):347-356 (Jan. 30, 1997).
Ingallinella, Paolo, et al., “Potent Peptide Inhibitors of Human Hepatitis C Virus NS3 Protease Are Obtained by Optimizing the Cleavage Products,” Biochemistry 37:8906-8914 (1998).
Kolykhalov, Alexander A., et al., “Specificity of the Hepatitis C Virus NS3 Serine Protease: Effects of Substitutions at the 3/4A, 4A/4B, 4B/5A and 5A/5B Cleavage Sites on Polyprotein Processing,” Journal of Virology 68(11):7525-7533 (Nov. 1994).
Komoda, Yasumasa, et al., “Substrate Requirements of Hepatitis C Virus Serine Proteinase for Intermolecular Polypeptide Cleavage inEscherichia coli,” Journal of Virology 68(11):7351-7357 (Nov. 1994).
Landro, James A., et al., “Mechanistic Role of an NS4A Peptide Cofactor with the Truncated NS3 Protease of Hepatitis C Virus: Elucidation of the NS4A Stimulatory Effect via Kinetic Analysis and Inhibitor Mapping,” Biochemistry 36:9340-9348 (1997).
Llinas-Brunet, Montse, et al., “Peptide-Based Inhibitors of the Hepatitis C Virus Serine Protease,” Bioorganic & Medicinal Chemistry Letters 8:1713-1718 (1998).
Marchetti, Antonella, et al., “Synthesis of Two Novel Cyclic Biphenyl Ether Analogs of an Inhibitor of HCV NS3 Protease,” Synlett S1:1000-1002 (1999).
Martin, F., et al., “Affinity selection of camelized VH domain antibody inhibitor of hepatitis C NS3 protease,” Protein Engineering 10(5):607-614 (1997).
Martin, Franck, et al., “Design of Selective Eglin Inhibitors HCV NS3 Proteinease,” Biochemistry 37:11459-11468 (1998).
Pizzi, Elisabetta, et al., “Molecular model of the specificity pocket of the hepatitis C virus protease: Implications for substrate recognition,” Proc. Natl. Acad. Sci. USA 91:888-892 (Feb. 1994).
BioWorld Today 9(217):4 (Nov. 10, 1998).
U.S. Appl. No. 10/052,386, filed Jan. 18, 2002.

Affiliated with

Also associated with

Rating

Depeptidized inhibitors of hepatitis C virus NS3 protease does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Depeptidized inhibitors of hepatitis C virus NS3 protease, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Depeptidized inhibitors of hepatitis C virus NS3 protease will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3898786